tiprankstipranks

NYBC Ventures Investment Portfolio

NYBC Ventures is the venture and commercialization arm of the New York Blood Center. It invests in, incubates and commercializes technologies and companies arising from NYBC’s research and operations, focusing on transfusion medicine, cell and gene therapies, diagnostics and related biomanufacturing, and manages technology transfer and licensing activities.

Companies Invested In

Company Name
Sector
Investment Round Value
Funding Round
Announcement Date
PC:AVENCAvenCell Therapeutics Inc
Healthcare, Biotechnology & Medical Devices
$112.00M
Series B
Aug 14, 2025